Longevity Consortium
Description: PROJECT NARRATIVE The longevity consortium will seek to integrate data and findings across 5 projects with different approaches to identifying factors influencing human longevity (studies of different species, drug testing, cell models, human association studies, and human studies of exceptional longevity and Alzheimer’s disease and related dementias). An integrated analysis and administrative core will facilitate appropriate interactions. The proposed level of integration is rarely seen in the biomedical sciences and will result in more reliable longevity-enhancing drug targets, candidate interventions, clinically useful biomarkers, and prediction models of health and longevity.
Funder: National Institute on Aging
Funding type: cooperative_agreement
Funder scheme: U19
Start date: 2004-09-30
End date: 2029-08-31
Investigator: THOMAS GIRKE (lead)
Institutions: Translational Genomics Research Institute, TRANSLATIONAL GENOMICS RESEARCH INST
Subfield: Aging
Domain: Life Sciences
Funded outputs count: 476
Funder award ID: U19AG023122
OpenAlex ID: G9000919024
